You are here

Improving Human Performance through Neuroenhancement

Award Information
Agency: Department of Defense
Branch: Special Operations Command
Contract: H9240519P0006
Agency Tracking Number: S182-002-0002
Amount: $149,991.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: SOCOM182-002
Solicitation Number: 2018.2
Timeline
Solicitation Year: 2018
Award Year: 2018
Award Start Date (Proposal Award Date): 2018-11-09
Award End Date (Contract End Date): 2019-05-09
Small Business Information
235 freeman apt 3, brookline, MA, 02116
DUNS: 080085661
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Noah Davidsohn
 (516) 473-1287
 noah@rejuvenatebio.com
Business Contact
 Daniel Oliver
Phone: (916) 396-3714
Email: dan@rejuvenatebio.com
Research Institution
N/A
Abstract
Special Operations Forces (SOF) are an integral aspect of the US military. SOF operators are among the most elite and highly qualified individuals in the U.S. military. As such, extraordinary physical and mental demands are placed upon them to excel in extreme environments for extended periods of time. This unrelenting cycle of combat deployments and intense pre-deployment training shortens the functional life of operators, a highly undesirable outcome. Rejuvenate Bio developed a gene therapy platform that identified genes that can increase the stress-resistance, health-span, and lifespan. We believe that these novel gene therapies will also enhance cognitive performance due to the neurotropic and brain specific genes being modulated. As a first step toward developing therapies for humans, we propose to measure the effect of these gene therapies on learning, memory, and focus.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government